Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan

Inclusion criteria

Patients who meet all of the following criteria.

• Patients with NYHA class II through IV chronic heart failure.
• Patients who have a history of hypertension or those who have antihypertensive medications.
• Patients who are aged 20 years or older and less than 80 years at the entry.
• Stable patients who have angiotensin converting enzyme inhibitor and/or beta-blocker.
• Patients who do not have angiotensin II receptor blocker.

Exclusion criteria

• Patients who have renal dysfunction (serum creatinine >=3.0mg/dL) or those who are receiving chronic hemodialysis.
• History of drug hypersensitivity to olmesartan.
• Patients who have severe liver dysfunction.
• History of angioedema.
• History of malignant tumor or life-threatening illness of poor prognosis.
• Pregnant or possibly pregnant patients.
• Cardiovascular surgery within 6months prior to the date of the entry.
• Acute myocardial infarction within 6 months prior to the date of the entry.
• Percutaneous coronary intervention or stent implantation within 6 months prior to the date of the entry.
• Other patients deemed unsuitable as subjects of the study by the treating physician.